EUCTR2007-003016-60-DK进行中（未招募）不适用
A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Subjects with Knee Osteoarthritis.
ordic Bioscience A/S0 个研究点目标入组 920 人开始时间: 2007年9月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 920
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Ambulatory men and women with knee osteoarthritis, between 51 and 80 years old, in general good health.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Any disease or medication affecting the bone or cartilage metabolism (osteoporosis is allowed).
- •Conditions causing secondary osteoarthritis of the study joint
- •Obese study subjects with unilateral aggressive progressing knee OA.
- •Malignancy (except basal cell carcinoma, cervical or breast ductal carcinoma in situ) within the last 5 years.
- •Any clinical signs or laboratory evidence for severe renal/liver/pulmonary, neurologic, cardiovascular, metabolic, hematological or psychiatric condition, which in the Investigator’s opinion would preclude the participant from adhering to the Protocol or completing the trial.
- •Diagnostic arthroscopy with a surgical procedure within 6 moths prior to the screening or plan to have a surgery during the clinical trial.
- •History of drug abuse or active alcoholism.
- •Any investigational drug(s) within 30 days prior to screening.
研究者
相似试验
进行中（未招募）
1 期
A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Calcitonin in the Treatment of Postmenopausal Women Taking Calcium and Vitamin D. - NDEUCTR2005-002984-10-ITORDIC BIOSCIENCE4,500
进行中（未招募）
1 期
A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Subjects with Knee Osteoarthritis.Un estudio aleatorizado, doble ciego, multicéntrico, controlado con placebo para evaluar la eficacia y la seguridad de calcitonina de salmón oral en el tratamiento de sujetos con osteoartritis de rodilla.OsteoarthritisEUCTR2007-003016-60-ESordic Bioscience A/S920
进行中（未招募）
1 期
A Clinical Study to test the effect of the drug Itraconazole (PUR1900) in Adult Asthmatic Patients with Allergic Bronchopulmonary AspergillosisAsthma with Allergic Bronchopulmonary AspergillosisMedDRA version: 20.1Level: PTClassification code 10006474Term: Bronchopulmonary aspergillosis allergicSystem Organ Class: 10021881 - Infections and infestationsEUCTR2018-002949-11-PLPulmatrix, Inc.64
进行中（未招募）
不适用
A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Subjects with Knee Osteoarthritis.OsteoarthritisEUCTR2007-003016-60-BEordic Bioscience A/S920
进行中（未招募）
不适用
A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Subjects with Knee Osteoarthritis.This is a phase III trial.The population will be ambulatory men and women with knee osteoarthritis between 51 and 80 years old, in general good health.MedDRA version: 9.1Level: LLTClassification code 10031161Term: OsteoarthritisEUCTR2005-004145-34-DKordic Bioscience A/S1,150